Abstract Details

Title Ocular Myasthenia Gravis: Treatment Successes and Failures in Patients with Long Term Follow up

Topic Muscle Disease/Neuromuscular Junction

Presentation(s) (-)

Poster/Presentation
Number 002

Objective

Background

Design/Methods

Results

Conclusions

Authors/Disclosures
Mark J. Kupersmith, MD, FAAN (Icahn School of Medicine At Mount Sinai)	Dr. Kupersmith has received personal compensation in the range of $10,000-$49,999 for serving as an Expert Witness for Legal firms. Dr. Kupersmith has stock in SafeTherapeutics m,LLC. The institution of Dr. Kupersmith has received research support from NEI, NYEEI FDN, Shulman Family NAION fund. Dr. Kupersmith has received intellectual property interests from a discovery or technology relating to health care.
	No disclosure on file

��ɫ����